Literature DB >> 16242163

In vitro and ex vivo distribution of [3H]harmane, an endogenous beta-carboline, in rat brain.

Neil J Anderson1, Robin J Tyacke, Stephen M Husbands, David J Nutt, Alan L Hudson, Emma S J Robinson.   

Abstract

The endogenous beta-carboline, harmane, has been shown to bind to monoamine oxidase A (MAO-A) and a separate, high affinity, non-MAO site. Research in our laboratory has shown that harmane is an active component of clonidine-displacing substance (CDS), the proposed endogenous ligand for imidazoline binding sites (IBS). In the present study we have investigated the distribution of [3H]harmane in rat brain, and related the binding profile to the distribution of the MAO-A selective ligand [3H]Ro41-1049 and the I2BS ligand [3H]2-BFI. The in vivo distribution of [3H]harmane following intravenous administration was also investigated. Receptor autoradiography revealed a highly significant correlation for the distribution of [3H]harmane and [3H]Ro41-1049, and a significant correlation for [3H]harmane and the I2BS ligand [3H]2-BFI. The in vivo distribution of [3H]harmane suggests that the ligand accumulates in the adrenal gland and throughout the brain with the primary route of excretion occurring via the duodenum. In conclusion, these studies have shown that [3H]harmane labels a population of binding sites that reflect the distribution of MAO-A. Further evidence for a non-MAO, IBS [3H]harmane population has not been shown but the high level of expression of the MAO-A site is likely to have masked the much smaller population of I2BS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242163     DOI: 10.1016/j.neuropharm.2005.08.022

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  11 in total

1.  Distribution and cellular localization of imidazoleacetic acid-ribotide, an endogenous ligand at imidazol(in)e and adrenergic receptors, in rat brain.

Authors:  Victor L Friedrich; Giorgio P Martinelli; George D Prell; Gay R Holstein
Journal:  J Chem Neuroanat       Date:  2007-01-08       Impact factor: 3.052

2.  Relationship between blood harmane and harmine concentrations in familial essential tremor, sporadic essential tremor and controls.

Authors:  Elan D Louis; Wendy Jiang; Marina Gerbin; Mary M Mullaney; Wei Zheng
Journal:  Neurotoxicology       Date:  2010-08-11       Impact factor: 4.294

3.  Dietary epidemiology of essential tremor: meat consumption and meat cooking practices.

Authors:  Elan D Louis; Garrett A Keating; Kenneth T Bogen; Eileen Rios; Kathryn M Pellegrino; Pam Factor-Litvak
Journal:  Neuroepidemiology       Date:  2008-04-02       Impact factor: 3.282

4.  Cancer and blood concentrations of the comutagen harmane in essential tremor.

Authors:  Elan D Louis; Kathryn M Pellegrino; Pam Factor-Litvak; Eileen Rios; Wendy Jiang; Claire Henchcliffe; Wei Zheng
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

5.  Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain.

Authors:  Elan D Louis; Julian Benito-León; Sara Moreno-García; Saturio Vega; Juan Pablo Romero; Felix Bermejo-Pareja; Marina Gerbin; Amanda S Viner; Pam Factor-Litvak; Wendy Jiang; Wei Zheng
Journal:  Neurotoxicology       Date:  2012-09-12       Impact factor: 4.294

6.  Higher blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations correlate with lower olfactory scores in essential tremor.

Authors:  Elan D Louis; Eileen Rios; Kathryn M Pellegrino; Wendy Jiang; Pam Factor-Litvak; Wei Zheng
Journal:  Neurotoxicology       Date:  2008-03-18       Impact factor: 4.294

7.  Elevated brain harmane (1-methyl-9H-pyrido[3,4-b]indole) in essential tremor cases vs. controls.

Authors:  Elan D Louis; Pam Factor-Litvak; Xinhua Liu; Jean-Paul G Vonsattel; Monika Galecki; Wendy Jiang; Wei Zheng
Journal:  Neurotoxicology       Date:  2013-08-02       Impact factor: 4.294

Review 8.  Environmental epidemiology of essential tremor.

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2008-08-21       Impact factor: 3.282

9.  Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor.

Authors:  Elan D Louis; Wendy Jiang; Kathryn M Pellegrino; Eileen Rios; Pam Factor-Litvak; Claire Henchcliffe; Wei Zheng
Journal:  Neurotoxicology       Date:  2007-12-27       Impact factor: 4.294

10.  Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in Parkinson's disease.

Authors:  Elan D Louis; Monika Michalec; Wendy Jiang; Pam Factor-Litvak; Wei Zheng
Journal:  Neurotoxicology       Date:  2013-12-01       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.